MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-04-2025
Orthofix Medical Total Assets 2011-2025 | OFIX
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets Orthofix Medical
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 893 M | 925 M | 459 M | 477 M | 526 M | 496 M | 467 M | 405 M | 372 M | 400 M | 393 M | 423 M | 504 M | 696 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 925 M | 372 M | 531 M |
Quarterly Total Assets Orthofix Medical
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 833 M | 837 M | 823 M | 893 M | 868 M | 882 M | 906 M | 925 M | 906 M | 901 M | 917 M | 459 M | 450 M | - | 462 M | 477 M | 500 M | 502 M | 514 M | 526 M | 526 M | 526 M | 526 M | 496 M | 496 M | 496 M | 496 M | 467 M | 467 M | 467 M | 467 M | 405 M | 405 M | 405 M | 405 M | 372 M | 372 M | 372 M | 372 M | 400 M | 400 M | 400 M | 400 M | 393 M | 393 M | 393 M | 393 M | 412 M | 412 M | 412 M | 412 M | 465 M | 473 M | 473 M | 473 M | 685 M | 704 M | 704 M | 696 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 925 M | 372 M | 545 M |
Total Assets of other stocks in the Medical devices industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Apyx Medical Corporation
APYX
|
79.2 M | $ 3.86 | -3.26 % | $ 134 M |  USA |
 |
BioSig Technologies
BSGM
|
842 K | - | 37.08 % | $ 85.7 M | USA |
 |
Abiomed
ABMD
|
1.49 B | - | - | $ 17.2 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
224 M | - | - | $ 1.77 B | USA |
 |
Cutera
CUTR
|
346 M | - | -10.19 % | $ 1.99 M | USA |
 |
Eargo
EAR
|
132 M | - | - | $ 10.2 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
10.6 M | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
9.36 B | $ 307.92 | -1.93 % | $ 8.69 B | USA |
 |
Apollo Endosurgery
APEN
|
110 M | - | - | $ 475 M | USA |
 |
Acutus Medical
AFIB
|
54 M | - | -26.83 % | $ 2.62 M | USA |
 |
Bruker Corporation
BRKR
|
5.81 B | $ 45.13 | -2.67 % | $ 6.72 K | USA |
 |
Allied Healthcare Products
AHPI
|
19.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Conformis
CFMS
|
94 M | - | - | $ 16.4 M | USA |
 |
Abbott Laboratories
ABT
|
81.4 B | $ 125.1 | 1.48 % | $ 218 B | USA |
 |
Boston Scientific Corporation
BSX
|
39.4 B | $ 92.34 | 0.64 % | $ 136 B | USA |
 |
CryoLife, Inc.
CRY
|
789 M | - | -4.14 % | $ 702 M | USA |
 |
EDAP TMS S.A.
EDAP
|
86.1 M | $ 2.56 | 8.94 % | $ 95.5 M |  France |
 |
Invacare Corporation
IVC
|
771 M | - | - | $ 24.7 M | USA |
 |
Cardiovascular Systems
CSII
|
323 M | - | 0.15 % | $ 844 M | USA |
 |
IRIDEX Corporation
IRIX
|
34.4 M | $ 0.92 | -4.72 % | $ 14.8 M | USA |
 |
IRadimed Corporation
IRMD
|
98.3 M | $ 96.35 | -1.06 % | $ 1.22 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
473 M | $ 17.7 | -3.46 % | $ 408 M | USA |
 |
Soliton, Inc.
SOLY
|
33.8 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
10.5 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
64.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
204 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
66.2 M | - | - | $ 111 M |  Canada |
 |
LivaNova PLC
LIVN
|
2.51 B | $ 62.79 | -1.82 % | $ 3.41 B |  Britain |
 |
Pulmonx Corporation
LUNG
|
163 M | $ 2.53 | 0.86 % | $ 99 M | USA |
 |
Dynatronics Corporation
DYNT
|
15.4 M | - | 14.99 % | $ 929 K | USA |
 |
Intersect ENT, Inc.
XENT
|
227 M | - | - | $ 955 M | USA |
 |
InMode Ltd.
INMD
|
786 M | $ 14.56 | 0.76 % | $ 1.15 B | Israel |
 |
Cognyte Software Ltd.
CGNT
|
498 M | $ 9.88 | 0.05 % | $ 709 M | Israel |
 |
Myomo
MYO
|
10.2 M | $ 1.06 | -1.85 % | $ 7.47 M | USA |
 |
Second Sight Medical Products
EYES
|
41.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
4.04 B | $ 13.41 | -4.56 % | $ 1.03 B | USA |
 |
NuVasive
NUVA
|
2.22 B | - | - | $ 2.07 B | USA |
 |
Align Technology
ALGN
|
6.21 B | $ 165.15 | 0.78 % | $ 12.4 B | USA |
 |
Accuray Incorporated
ARAY
|
470 M | $ 1.07 | -3.18 % | $ 110 M | USA |
 |
Avinger
AVGR
|
13.8 M | - | -20.74 % | $ 369 K | USA |
 |
ClearPoint Neuro
CLPT
|
39.2 M | $ 12.81 | -1.23 % | $ 346 M | USA |
 |
FONAR Corporation
FONR
|
199 M | $ 14.86 | -0.03 % | $ 97.4 M | USA |
 |
AxoGen
AXGN
|
204 M | $ 30.33 | 1.15 % | $ 1.34 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
659 M | - | - | $ 3.31 B | USA |
 |
GBS
GBS
|
8.25 M | - | -0.57 % | $ 7.12 M | USA |
 |
CONMED Corporation
CNMD
|
2.31 B | $ 40.78 | 2.33 % | $ 1.26 B | USA |
|
LENSAR
LNSR
|
66.3 M | $ 11.48 | -0.17 % | $ 132 M | USA |